Pneumonia

In: Other Topics

Submitted By mowebb14
Words 4013
Pages 17
Pneumonia

Over the years, many people have found new research on Pneumonia. In Latin, “pnemon” means lungs, “-ia” is the pathological condition, and “-itis” means inflammation. Hippocrates was the first person, on record, to discover pneumonia. He lived during the years of 60BC – 370BC. The “Father or Medicine” was one of the names this Greek physician was considered as in history. Pneumonia descriptions was most accurately given from a Jewish philosopher and physician, who goes by the name Moses ben-Maimom. Even though they were the most accurate, doesn’t mean they are the most current. He lived from 1135AD – 1240AD. Edwin Klebs discovered that bacteria was the cause of pneumonia in 1875. He found this out while studying bacteria in airways of pneumonia patients who died. Klebs was a German-Swiss Pathologist. Bacterial genus Klebsiella is named after him. In 1882 and 1884, Carl Friedländer and Albert Fränkel found the two main causes of Pneumonia, which were Klebsiella pneumoniae and Streptococcus pneumoniae. Through Friedländer’s research, the Gram Stain was introduced and helps identify the two types of bacteria that cause pneumonia.
Klebsiella pneumoniae is a respiratory pathogen that causes pneumonia. This bacteria is found most of the time in the gastrointestinal tract and the nasopharnyx. Another common place it is found is on hands of hospital workers. This bacteria is not only in humans, it is everywhere in the ecological environment. It has been correlated worldwide with infections. There are two types of infections, community-acquired or hospital-acquired. Alcoholism is associated with community-acquired Klebsiella pneumonia. If patients have an immune deficiency, then Klebsiella pneumoniae caused diseases may lead to their death. This is because the patient’s immune system cannot fight against the bacteria that is causing the infection. A person has…...

Similar Documents

Pneumonia

...INTRODUCTION Pneumonia is an inflammation of the lungs caused by an infection. It is also called Pneumonitis or Bronchopneumonia. Pneumonia can be a serious threat to our health. Although pneumonia is a special concern for older adults and those with chronic illnesses, it can also strike young, healthy people as well.  It is a common illness that affects thousands of people each year in the Philippines, thus, it remains an important cause of morbidity and mortality in the country. There are many kinds of pneumonia that range in seriousness from mild to life-threatening. In infectious pneumonia, bacteria, viruses, fungi or other organisms attack your lungs, leading to inflammation that makes it hard to breathe. Pneumonia can affect one or both lungs. In the young and healthy, early treatment with antibiotics can cure bacterial pneumonia. The drugs used to fight pneumonia are determined by the germ causing the pneumonia and the judgment of the doctor. It’s best to do everything we can to prevent pneumonia, but if one do get sick, recognizing and treating the disease early offers the best chance for a full recovery. A case with a diagnosis of Pneumonia may catch one’s attention, though the disease is just like an ordinary cough and fever, it can lead to death especially when no intervention or care is done. Since the case is a toddler, an appropriate care has to be done to make the patient’s recovery faster. Treating patients with pneumonia is necessary to prevent its spread......

Words: 898 - Pages: 4

Pneumonia Case Study

...I. Introduction This is a case of a 74 year old woman who was diagnosed with Community Acquired Pneumonia. Pneumonia is an inflammation or infection of the lungs most commonly caused by a bacteria or virus. Pneumonia can also be caused by inhaling vomit or other foreign substances. In all cases, the lungs' air sacs fill with pus , mucous, and other liquids and cannot function properly. This means oxygen cannot reach the blood and the cells of the body. Most pneumonias are caused by bacterial infections.The most common infectious cause of pneumonia in the United States is the bacteria Streptococcus pneumoniae. Bacterial pneumonia can attack anyone. The most common cause of bacterial pneumonia in adults is a bacteria called Streptococcus pneumoniae or Pneumococcus. Pneumococcal pneumonia occurs only in the lobar form. An increasing number of viruses are being identified as the cause of respiratory infection. Half of all pneumonias are believed to be of viral origin. Most viral pneumonias are patchy and the body usually fights them off without help from medications or other treatments. Pneumococcus can affect more than the lungs. The bacteria can also cause serious infections of the covering of the brain (meningitis), the bloodstream, and other parts of the body. Community-acquired pneumonia develops in people with limited or no contact with medical institutions or settings. The most commonly identified pathogens areStreptococcus pneumoniae, Haemophilus influenzae, and...

Words: 1647 - Pages: 7

Pneumonia

...Modifiable Factors: PLEURAL EFFUSION SECONDARY TO COMMUNITY ACQUIRED PNEUMONIA Non Modifiable factors: Underlying diseases Pneumonia, COPD Cardiovascular disease Diabetes mellitus Genetic The immunocompromised or immunosuppressed patients with low neutrophil count Age: Very young and of 60-70 yrs old Lifestyle Gender More t in males than in females Environment Exposure to Pathogens: S. Pneumoniae, H. Influenza, Lagionella, P. Aureginosa, other gram (-) rods and viruses Exposure and inhalation of Secondhand smoke and other chemical pollutants Smoking and Alcohol abuse Inhalation of foreign materials Improper diet and malnutrition Decreased/Disruption of mucocilliary and macrophage activity Decreased immune response or immunosuppresion Bacterial invasion in lower respiratory tract Inflammatory response Lymphocytes produce cytokinse Immune Response Triggered Increase WBC Filling of WBC in alveoli Release of chemical mediators (bradykinins, histamins, etc) Release of T- cells, macrophages phagocytes and atntibodies Crackles Immune Response Triggered Vasodilation and increase capillary permeability Dyspnea Cough with purulent yellowish secretions Non- productive cough WBC takes effect to......

Words: 338 - Pages: 2

Pneumonia

...CASE STUDY: PNEUMONIA SUBJECTIVE: This is a 63 year old female with complain of cough for 1-week with yellowish sputum accompanied with fever and chills at home. She denies current chest pain during examination but claims of on and off chest pain episodes for about 5 days from the visit. She complains of having shortness of breath for 2 weeks. She went to ER 6 days ago with fever of 100.4 ḟ. She reports a Computed Tomographic Pulmonary Angiography (CTPA), which was negative for Pulmonary Embolism (PE) but found positive for Pneumonia. Patient reports to take antibiotic started during the ER visit but has not been taking the breathing treatment at home. The patient has no known drug allergy. Patient denies postnasal drip and sneezing and no hemoptysis. Patient denies any abdominal pan, nausea, vomiting, diarrhea, lower extremity swelling nor dysuria. He also denies smoking. Past Medical History is coronary artery disease with stent, hyperlipidemia, hypertension, diabetes mellitus, CKD, Stage 3 (GFR 30-59), anxiety disorder, stridor 2nd to history of intubation and tracheostomy, gastric rectal bleeding with chronic anemia, major Depression – recurrent, non-alcoholic cirrhosis, obesity (BMI-30-39.9), obstructive sleep apnea and venous stasis. OBJECTIVE: PHYSICAL ASSESSMENT Ht. 5’1, Wt. 175 lbs. BMI = 33.1 VS are BP 155/69, HR= 83-97, T 37.7, RR 32, SpO2 91-93% @ 2L O2 by nasal cannula General: She appears to be calm and breathing fairly, saturating well without oxygen......

Words: 699 - Pages: 3

Doh Adds Vaccine vs Pneumonia to Immunization Program

...DOH adds vaccine vs pneumonia to immunization program July 17, 2013 10:31am    Tags: Department of Health The Department of Health has added free anti-pneumonia vaccination to its immunization program for children in the country's health centers. DOH Secretary Enrique Ona said this is another historic milestone to the DOH's Expanded Program on Immunization (EPI).   “We are introducing the Pneumococcal Conjugate Vaccine (PCV) to the Philippine vaccination program for infants,” Ona said on the DOH's Facebook page. “This is part of our goal to achieve better health outcomes and meet our health-related Millennium Development Goals by strengthening existing public health programs, such as expanding immunization interventions,” he added. Ona said the vaccine would have cost P2,050 per child, including three doses of the PCV. He added Filipinos may have to spend up to P23,500 for hospitalization, including professional fee, consultation, laboratory tests and medication. The DOH cited Philippine health statistics for 2010 showing pneumonia is the second leading cause of infant mortality, accounting for 2,628 deaths.   ARMM, Caraga first beneficiaries The DOH said the integration of the PCV will be done by phases, with Autonomous Region in Muslim Mindanao and Caraga being the first beneficiaries of the program. "Additional regions will be included every year for administration of pneumococcal vaccines until 100 percent of the regions are covered," the......

Words: 367 - Pages: 2

Ventilator Associated Pneumonia

...Running head: A QUALITATIVE ANALYSIS OF CLINICIANS' PERCEPTION OF A Qualitative Analysis of Clinicians' Perception of Head-of-Bed Elevation Jolly Abraham Grand Canyon University NRS-433V January 09, 2011 A Qualitative Analysis of Clinicians' Perception of Head-of-Bed Elevation Ventilator - associated pneumonia (VAP) is the second most common hospital acquired infection (HAI) and is associated with high morbidity and mortality rates for ventilated patients in intensive care units (Bingham, Ashley, Jong, & Swift, 2010). The VAP increases patients’ mortality rates, length of stay and hospital costs (Hiner, Kasuya, Cottingham, & Whitney, 2010). The VAP is the leading causes of death due to nosocomial infections and the second most common nosocomial infection in the United States (Hiner et al., p. 164). The VAP is a serious and life threatening infection to critically ill patients and prevention of VAP is an ongoing challenge to critical care nurses. The purpose of this research was to investigate clinicians’ ability to estimate the head of the bed elevation (HOB) levels, assess their knowledge regarding the recommended guidelines of head of the bed elevations and to find out how they determine angle of the HOB in their practice (Hiner et al.). The study suggests that clinicians’ perception of head of the bed elevation play a significant role in helping to achieve the goal of elevating the HOB to 300 to 450(Hiner et al., 2010, p. 165). The study design and......

Words: 1151 - Pages: 5

Pneumonia Case Studt

...Pneumonia Case Study August 27th, 2014 Mrs. Yolanda Bone South University Pneumonia Case Study A major cause of morbidity and mortality is Pneumonia. Pneumonia is a lung infection caused by bacteria, fungi or viruses (Center for Disease Control, 2014).The infection is classified into two categories; community-acquired pneumonia (CAP) or health care-associated pneumonia (HCAP). The classification is determined by the environment in which the infection develops (CDC, 2014). HCAP develops during or following a stay in a healthcare facility. In contrast, patients who are diagnosed with CAP have had no contact within a health care setting prior to presenting with the infection (Driver, 2012). Pneumonia may be present as a mild illness but has the potential to be life-threatening. Despite advances in research, pneumonia remains a common illness contributing to the death of young children in developing countries and the elderly population of developed countries throughout the world (Ruuskanen, et al., 2011). In 2010, approximately 50,000 people in the U.S. died after developing the infection (CDC, 2014). From a global perspective, 450 million cases of pneumonia are recorded annually and roughly 4 million of those diagnosed will die from this illness (Ruuskanen, et al., 2011). CAP is the eighth-leading cause of death within the U.S. and is the leading cause of death from infection in the developed world (Brown, et al., 2012). While anyone is susceptible to......

Words: 3087 - Pages: 13

Prevention of Ventilator-Associated Pneumonia

...Prevention of Ventilator-Associated Pneumonia Prevention of Ventilator-Associated Pneumonia Ventilator-Associated Pneumonia (VAP) is the most common nosocomial infection in Critical Care units. VAP is linked with high mortality rates, increased hospital stays, longer mechanical ventilation and increased costs to hospitals and patients (Rosa, Hernandez, Carillo, Fernandez, & Valles, 2012). Patients who have an endotracheal tube (ETT) with mechanical ventilation are more likely to develop VAP. These patients have a poor cough reflex due to a decreased level of consciousness and diminished movement of the respiratory tract mucocila, leading to the inability to clear secretions. These contaminated secretions will then sit on top of the ETT cuff and eventually leak down and invade the lungs. Also aiding as a reservoir for microbes is a biofilm that can form on the ETT and enter the lungs causing infection (Mietto, Pinciroli, Patel, & Berra, 2013). Nurses are responsible for applying pharmacological and non-pharmacological measures to help prevent VAP which poses a very difficult challenge. Nurses must research and incorporate the use of evidence-based practice into their daily care of patients on mechanical ventilation (Sedwick, Lance-Smith, & Nardi, 2012). This paper will look closely at the evidence-based research and protocols implemented which best prevent ventilator-associated pneumonia. To help prevent further complications and improve outcomes in......

Words: 2122 - Pages: 9

Respiratory Health

...Respiratory Disease Paper - Pneumonia Ranacia Alford HCS/245 October 16, 2014 Heather Walzel Respiratory Disease Paper – Pneumonia Introduction Pneumonia, by terminological definition, is an infection of the lungs. It can be caused by bacteria, viruses, and other microbial organisms that invade the body. Pneumonia has the potential to be an advantageous disease in that it can attack when the body is infected by another microbial, such as a upper respiratory infection (Kid’s Health, 2011). Pneumonia can also be contracted by inhaling a liquid or chemical into the lungs (National Institutes of Health [NIH], 2014). Pneumonia may affect anyone from children to adults. This disease can be prevented and treated. Disease Prevention Type Pneumonia falls under more than one prevention type category. Primary prevention of pneumonia in the form of vaccines is an effective method among children and the elderly. The infant vaccine series of the pneumococcal vaccine, Prevnar, has been incorporated into the Centers for Disease Control and Prevention’s recommended immunizations for infants between ages two months and eighteen months (Centers for Disease Control and Prevention [CDC], 2014). Other vaccines also contribute to prevention including Hib, Flu, and Pertussis (CDC, 2014). Because they're at higher risk for serious complications, infants born prematurely may be given treatments that temporarily protect against RSV, which can lead to pneumonia in younger kids (Kid’s Health,...

Words: 845 - Pages: 4

Patho on Pneumonia

...Infections are caused by an invasion of unwanted organisms that attack ones body. With that being said, pneumonia is an acute infection of the lung parenchyma (Anatomical Chart Company, 2010, p. 100). Pneumonia, like any other infection, has a pathophysiology that describes how the infection affects the body. It also has different causes, several signs and symptoms, a variety of different treatments, and even a long list of possible complications. Pneumonia is always handled with delicate attention, but for individuals who have normal, healthy lungs and a strong immune system the final outcome is almost always a good one. Serious attention needs to be focused on those who are at a greater risk such as the elderly, children, and the immunocomprimised (Anatomical Chart Company, 2010, p. 100). According to the Atlas of Pathophysiology, there are three different basic types of pneumonia: bacterial, viral, and aspiration. The primary cause of pneumonia is an inhalation or aspiration of a pathogen. The secondary cause is related to an existing infection or disease. Each of these are caused by different irritants that result in the same disruption of normal perfusion. The attacks on the lung lead to alveolar inflammation and edema that causes low ventilation and blood and fluid to be pushed into the capillaries. This leads to a stasis in the lung’s gas perfusion and creates a pressure that makes it harder for the individual to breath (Anatomical Chart Company, 2010, p. 100). The...

Words: 570 - Pages: 3

Ventialtor Associated Pneumonia

...the confinement. Our Respiratory System is responsible for the breathing process of our body. Once infection arises it can delay and agrravate once patient’s condition and would subsequently deteriorate leaving sometimes major organs be affected,this what we call the multi-organ failure. Pnemonia as we all know is one of the most common nosocomial infections and one of the leading causes of death inside the hospital.It is defined as an inflammation of the lungs. Hospital-Acquired Pneumonia is one of the most common kind of it. It a pneumonia that has been acquired during or after one’s hospitalization for another illness with onset of at least 72 hours after admission. Once a patient has been admitted to Intensive Care Unit,it is very likely that the patient could be able to acquire this infection and so much more if patient ended up to be intubated and mechanically ventilated,a type of Pneumonia would be likely to be developed,this is known as the Ventilator Associated Pneumonia....

Words: 277 - Pages: 2

Ventilated Associated Pneumonia

...Ventilator Associated Pneumonia and Guidelines VAP: Definition • Pneumonia in patients receiving invasive mechanical ventilation for at least 48 hours • Early VAP: < 4 days in the ICU • Late VAP: > 4 days in the ICU VAP: Incidence US National Nosocomial Infection Surveillance Type of ICU Mean VAP Rate (Cases/1000 vent days) Trauma 15.1 Neurosurgical Surgical Burn Cardiothoracic 12.9 9.9 9.6 7.9 Data from January 2002 – June 2003 Reported as VAP rates/1000 vent days VAP: Burden of Illness • Incidence 10-20% of patients receiving mechanical ventilation > 48 hours • Increased ICU Mortality (2-4 times) • Increased ICU LOS (5-7 days) • Increased hospital costs (>$10,000 US in additional costs) Safdar et al, Crit Care Med, 2005; 33: 2184 VAP: Healthcare Cost Burden of Illness Canada (per year) (10.6 cases/1000 Vent days) Excess Vent days Excess Deaths1 16,000 days (55 ICU beds) 216 Excess Cost2 $46,000,000 1Based on attributable mortality of 5.8% cost cost methodology 2Ontario Clinical Criteria for Suspicion of VAP • New or persistent infiltrate on CXR without another cause • Plus any 2 of the following: • • • • Purulent endotracheal secretions Increasing oxygen requirements Core temperature > 38.0o C WBC < 3.5 or > 11.0 Adapted from N Engl J Med 2006;355:2619-30. Host Risk Factors for VAP • Underlying pulmonary disease......

Words: 526 - Pages: 3

Ventilator Associated Pneumonia

...…………………………..……………………………7 Power analysis …………………………………..…………….……………………………8 Instrumentation ...............................................................................................................…...8 Data collection ……………………………………..………….……………………………8 Statistics and data analysis …………………………………………………………….…...9 Expected results …………………………………………………………………………………..9 References cited………………………………………………………………………………….10 Appendix A………………………………………………………………………………………13 Appendix B………………………………………………………………………………………14 Appendix C………………………………………………………………………………………15 Appendix D………………………………………………………………………………………16 Ventilator associated pneumonia and chlorhexidine use in the traumatic brain injured patient Ventilator associated pneumonia (VAP), is defined as, a nosocomial pneumonia that develops more than 48 hours following endotrachial intubation and mechanical ventilation, and is a common and serious intensive care unit (ICU) complication. VAP causes noteworthy morbidity, mortality, amplified hospital costs, and increased utilization of healthcare resources, prolonged time for ventilator support, as well as lengthened ICU and hospital stay (Caruso, 2009). Antibiotics (ATBs) have traditionally been used to treat VAP, but the occurrence of resistance remains of concern (Derde & Bonten, 2009). Therefore, the use of a chlorhexidine (CHX) solution, used during oral cleansing, performed by nursing staff, appears to be an attractive and......

Words: 2745 - Pages: 11

Pneumonia

...LAPORAN PENDAHULUAN A.    DEFINISI          Pneumonia adalah suatu peradangan atau inflamasi pada parenkim paru yang umumnya disebabkan oleh agent infeksi. B.     ETIOLOGI Pneumonia dapat disebabkan oleh bermacam-macam etiologi seperti:        1.Bakteri: stapilokokus, streplokokus, aeruginosa, eneterobacter        2.Virus: virus influenza, adenovirus        3.Micoplasma pneumonia        4.Jamur: candida albicans        5. Aspirasi: lambung C.     PATOFISIOLOGI  Sebagian besar pneumonia didapat melalui aspirasi partikel infektif. Ada beberapa mekanisma yang pada keadaan normal melindungi paru dari infeksi. Partikel infeksius difiltrasi di hidung, atau terperangkap dan dibersihkan oleh mukus dan epitel bersilia di saluran napas. Bila suatu partikel dapat mencapai paru-paru, partikel tersebut akan berhadapan dengan makrofag alveoler, dan juga dengan mekanisme imun sistemik, dan humoral. Bayi pada bulan-bulan pertama kehidupan juga memiliki antibodi maternal yang didapat secara pasif yang dapat melindunginya dari pneumokokus dan organisme-organisme infeksius lainnya. Perubahan pada mekanisme protektif ini dapat menyebabkan anak mudah mengalami pneumonia misalnya pada kelainan anatomis kongenital, defisiensi imun didapat atau kongenital, atau kelainan neurologis yang memudahkan anak mengalami aspirasi dan perubahan kualitas sekresi mukus atau epitel saluran napas. Pada anak tanpa faktor-faktor predisposisi tersebut, partikel infeksius dapat mencapai paru melalui......

Words: 1217 - Pages: 5

Outcome of Ventilator-Associated Pneumonia: Impact of Antibiotic Therapy and

...Australasian Medical Journal [AMJ 2012, 5, 2, 135-140] Outcome of ventilator-associated pneumonia: Impact of antibiotic therapy and other factors Noyal Mariya Joseph1, Sujatha Sistla1, Tarun Kumar Dutta2, Ashok Shankar Badhe3, Desdemona Rasitha1, Subhash Chandra Parija1 1. Department of Microbiology, 2. Department of Medicine, 3. Department of Anaesthesiology and Critical Care Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry - 605006, India RESEARCH Please cite this paper as: Joseph NM, Sistla S, Dutta TK, Badhe AS, Rasitha D, Parija SC. Outcome of ventilatorassociated pneumonia: impact of appropriate therapy and other factors. AMJ 2012, 5, 2, 135-140. http//dx.doi.org/10.4066/AMJ.2012.1004. Corresponding Author: Dr. Noyal Mariya Joseph, Assistant Professor, Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pillaiyarkuppam, Pondicherry – 607 402 (India) Email: noyaljoseph@yahoo.com Please use these fonts and font sizes only. Abstract inappropriate therapy (defined as lack of coverage of one or all the significant VAP pathogens) were at significantly high risk for death (Relative risk, 2.00; 95% confidence interval, 1.14 to 3.52; P 0.0008). A delay of > 2 days in administering the first dose of appropriate antibiotic therapy significantly prolonged the duration of ventilation (P < 0.0001). Infection by multi-drug resistant pathogens, polymicrobial infection and time of onset of VAP did......

Words: 3905 - Pages: 16